Human Holdings Co (2415) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
20 Jul, 2026Executive summary
Consolidated revenue for the six months ended September 30, 2024, increased 4.0% year-over-year to ¥49,158 million, with operating profit up 3.9% to ¥1,081 million and ordinary profit up 7.5% to ¥1,128 million.
Profit attributable to owners of parent was ¥605 million, nearly flat year-over-year, and earnings per share rose to ¥58.31 from ¥55.44.
All major business segments contributed to revenue growth, with the human resources segment showing the strongest gains.
Full-year guidance remains unchanged, with expectations to surpass previous record highs in both revenue and profit.
Financial highlights
Gross profit increased to ¥12,422 million from ¥11,886 million year-over-year.
Operating profit margin was 2.2% for the period, unchanged year-over-year.
Human resources segment revenue rose 5.4% year-over-year, with operating profit up 38.6%.
Education segment revenue increased 1.6%, but operating profit declined 69.2% due to upfront investments and temporary costs.
Care segment revenue grew 4.7%, with a slight decrease in operating profit due to higher personnel costs.
Outlook and guidance
Full-year revenue forecast is ¥99,300 million (+3.6% year-over-year), with operating profit projected at ¥3,300 million and ordinary profit at ¥3,350 million.
Profit attributable to owners of parent is forecast at ¥2,200 million, with full-year earnings per share of ¥211.99.
Dividend forecast for FY2025/3 is ¥64 per share (payout ratio 30.2%).
Progress toward full-year targets is on track for most segments, though education segment profit lags due to upfront costs, expected to recover in the second half.
Latest events from Human Holdings Co
- Quarterly revenue and profits increased, with a dividend hike and growth forecast.2415
Q1 202520 Jul 2026 - Record revenue and profit growth, improved margins, and higher dividends with steady outlook.2415
Q4 202520 Jul 2026 - Profits and sales rose, record outlook set, and shareholder returns were enhanced.2415
Q3 202520 Jul 2026 - Revenue and profits grew strongly, with record full-year results and extraordinary gains expected.2415
Q2 202620 Jul 2026 - Revenue and profit increased across all segments, led by human resources and nursing care.2415
Q1 202620 Jul 2026 - Revenue up 1.9% YoY, but profits dipped; outlook and dividend forecast remain strong.2415
Q3 202620 Jul 2026 - Revenue and operating profit rose, but net profit fell 15% on extraordinary losses.2415
Q4 202620 Jul 2026